Sign in

    Robert Goff

    Research Analyst at Echelon Wealth Partners

    Rob Goff is the Managing Director and Head of Research at Echelon Wealth Partners, specializing in technology, telecom, and new media sector analysis. He covers companies such as Playmaker Capital and Canaccord Genuity Group, and is known for providing actionable investment recommendations on these names, including performance-based ratings and price targets. With over 30 years of experience in the financial industry, Goff began his career after graduating from the Ivey Business School at Western University, holding influential research and analyst roles at firms such as Byron Capital Markets, Northland Capital Partners, Haywood Securities, Credit Suisse, Midland Walwyn, Scotia Capital Markets, and Mutual Life of Canada before joining Echelon. He holds an HBA in Business Administration and Management and possesses extensive industry credentials as a research analyst, consistently demonstrating leadership in the Canadian capital markets.

    Robert Goff's questions to Healwell AI (HWAIF) leadership

    Robert Goff's questions to Healwell AI (HWAIF) leadership • Q1 2025

    Question

    Robert Goff of Echelon Wealth Partners asked for more detail on the "Buy Canadian" opportunity and whether a similar "buy from Canada" or "buy from New Zealand" sentiment exists in other jurisdictions, creating a tailwind in RFP processes.

    Answer

    Executive Alexander Dobranowski highlighted a material opportunity within Canada, noting Healwell is in a strong position to compete for RFPs due to its combined capabilities. He also confirmed a similar pro-Commonwealth sentiment is felt in other jurisdictions, which could be a tailwind given Orion Health's historical success in those markets.

    Ask Fintool Equity Research AI